TMS Co., Ltd. (JP:4891) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
TMS Co., Ltd. has secured a U.S. patent for a new treatment for acute kidney injury using compounds including TMS-008, further strengthening its global intellectual property portfolio alongside recent grants in Japan and China. This development highlights TMS’s commitment to advancing innovative treatments in areas with high unmet medical needs.
For further insights into JP:4891 stock, check out TipRanks’ Stock Analysis page.